4 documents found, page 1 of 1
Clinical Standards for Diagnosis, Treatment and Prevention of Post-COVID-19 Lun...
Visca, D; Centis, R; Pontali, E; Zampogna, E; Russell, AM; Migliori, GB; Andrejak, C; Aro, M; Bayram, H; Berkani, K; Bruchfeld, J; Chakaya, JMBACKGROUND: The aim of these clinical standards is to provide guidance on 'best practice' care for the diagnosis, treatment and prevention of post-COVID-19 lung disease.METHODS: A panel of international experts representing scientific societies, associations and groups active in post-COVID-19 lung disease was identified; 45 completed a Delphi process. A 5-point Likert scale indicated level of agreement with the...
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
Casco, N; Jorge, AL; Palmero, DJ; Alffenaar, JW; Fox, GJ; Ezz, W; Cho, JG; Denholm, J; Skrahina, A; Solodovnikova, V; Arbex, MA; Alves, T; Rabahi, MFBackground Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes of patients affected by TB and COVID-19. Methods We collected data from 174 centres in 31 countries on all patients affected by COVID-19 and TB between 1 March 2020 and 30 September 2022. Patients were followed-up until cure, death or end...
New and repurposed drugs to treat multidrug- and extensively drug-resistant tub...
Silva, DR; Dalcolmo, M; Tiberi, S; Arbex, MA; Munoz-Torrico, M; Duarte, R; D'Ambrosio, L; Visca, D; Rendon, A; Gaga, M; Zumla, A; Migliori, GBMultidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respectively) continue to represent a challenge for clinicians and public health authorities. Unfortunately, although there have been encouraging reports of higher success rates, the overall rate of favorable outcomes of M/XDR-TB treatment is only 54%, or much lower when the spectrum of drug resistance is beyond that of XDR-TB. ...
Eliminating tuberculosis in Latin America: making it the point
Duarte, R; Silva, DR; Rendon, A; Alves, TG; Rabahi, MF; Centis, R; Kritski, A; Migliori, GBn/a